Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group(2019) Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors J Natl Compr Canc Netw, 17(5), 459-468 DOI 10.6004/jnccn.2018.7109, PubMed 31085753
Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ(2019) Second cancers in patients with locally advanced prostate cancer randomized to lifelong endocrine treatment with or without radical radiotherapy. Long term follow- up of the Scandinavian Prostate Cancer Group-7 trial Int J Radiat Oncol Biol Phys(in press) DOI 10.1016/j.ijrobp.2019.11.027, PubMed 31786279
Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Seland M, Wilsgaard T, Smeland KB, Kiserud CE(2019) Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation Bone Marrow Transplant(in press) DOI 10.1038/s41409-019-0745-4, PubMed 31745250
